Alkermes Plc · NASDAQ:ALKS
Hopkinson Craig C. sold 9,000 Alkermes Plc shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 1, 2026
On Sep 1, 2026, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) sold 9,000 Alkermes Plc shares at US$46.99 for US$423K under a trading plan, leaving 65,389 shares. Filed Sep 1, 2026 (Form 4).
- Sold
- 9,000 shares
- Price
- US$46.99
- Value
- US$423K
- Holding after
- 65,389 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP R&D, Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Ordinary Shares | Option exercise | 5,000 | US$24.59 | 74,389 | Direct |
| Sep 1, 2026 | Ordinary Shares | Sale | 9,000 | US$46.99 | 65,389 | Direct |
Source
Related
- Alkermes Plc
- Hopkinson Craig C.
- Alkermes Plc shareholders
- Form 4 · Hopkinson Craig C. · Aug 3, 2026
- Form 4 · Hopkinson Craig C. · Jul 1, 2026
- Form 4 · Hopkinson Craig C. · Jun 1, 2026
- Form 4 · Hopkinson Craig C. · May 1, 2026
- Form 4 · Hopkinson Craig C. · Apr 1, 2026
- Form 4 · Reed Joshua · Oct 9, 2026
- Form 4 · Gaffin David Joseph · Oct 2, 2026
- Form 4 · Gaffin David Joseph · Sep 3, 2026
- Form 4 · Nichols Christian Todd · Aug 17, 2026
- Form 4 · snyderman nancy lynn MD · Aug 3, 2026